STOCK TITAN

Walgreens Boots Alliance Inc - WBA STOCK NEWS

Welcome to our dedicated news page for Walgreens Boots Alliance (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreens Boots Alliance.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Walgreens Boots Alliance's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Walgreens Boots Alliance's position in the market.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.82%
Tags
none
-
Rhea-AI Summary
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) appoints Tom Polen, CEO of BD, to its board of directors, as the company accelerates its healthcare transformation and growth strategy. Polen brings over 25 years of healthcare solutions and technologies experience and will serve on the board's Finance and Technology Committee.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.82%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.37%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.54%
Tags
none
-
Rhea-AI Summary
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) announced financial results for Q3 2023, with sales increasing 8.6% YoY to $35.4 billion. Adjusted EPS grew 3.3% to $1.00. The company revised its full-year adjusted EPS guidance to $4.00 to $4.05. Immediate actions are being taken to improve profitability, including $600 million of cost savings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.34%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.05%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.23%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.19%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.16%
Tags
none
Walgreens Boots Alliance Inc

Nasdaq:WBA

WBA Rankings

WBA Stock Data

15.40B
712.96M
17.35%
62%
4.08%
Pharmacies and Drug Stores
Retail Trade
Link
United States
Deerfield

About WBA

walgreens boots alliance is the first global pharmacy-led, health and wellbeing enterprise. the company was created through the combination of walgreens and alliance boots in december 2014, bringing together two leading companies with iconic brands, complementary geographic footprints, shared values and a heritage of trusted health care services through pharmaceutical wholesaling and community pharmacy care, dating back more than 100 years. the company employs more than 370,000* people and has a presence in more than 25* countries; it is the largest retail pharmacy, health and daily living destination in the usa and europe. including its equity method investments, walgreens boots alliance is a global leader in pharmacy-led, health and wellbeing retail with over 13,100* stores in 11* countries. the company includes one of the largest global pharmaceutical wholesale and distribution networks with over 350* distribution centers delivering to more than 200,000** pharmacies, doctors, he